Directors and Advisers

Directors

Julian Baines, Non-Executive Chairman

Group CEO, EKF Diagnostics Holdings plc; former CEO & Managing Director BBI Holdings plc

James McCullough, MBA, CEO

Partner, Renwick Capital; former CEO, Exosome Diagnostics; co-Founder PAIGE.AI

Richard Evans, MBA

CFO EKF Diagnostics Holdings plc; Finance Manager, Global Account Director at Hitachi Data Systems

Christopher Mills

CEO and Partner, Harwood Capital LLP; CEO and Investment Manager North Atlantic Smaller Companies Investment Trust

Fergus Fleming, CTO

Managing Director, FF Consulting; former senior project manager, EKF Diagnostics Holdings plc

Barbara Murphy, MD

Murray M. Rosenberg Professor of Medicine; Chair of the Department of Medicine for the Mount Sinai Health System; Dean for Clinical Integration and Population Health

Erik Lium, PhD

Executive Vice President, Innovation Partners, Mount Sinai Health System

Chirag R Parikh, MD, PhD

Director, Division of Nephrology, Ronald Peterson Professor of Medicine, Johns Hopkins School of Medicine

Company Secretary

Salim Hamir, FCA

Chartered Accountant, Company Secretary and Head of Corporate Affairs EKF Diagnostics Holdings Plc

Senior Managers

O. James Sterling, CFO

Partner, Renwick Capital; former Managing Director, Brock Capital Group and Aleutian Capital Partners; management consultant, Booz Allen

Sally Bowden, COO

President of Bowden Consulting Group, Inc., focussing on quality and regulatory field in medical devices, companion diagnostics, education and health care systems

Thomas McLain, MBA, CPA, President and CCO

Formerly CEO and President, Exosome Diagnostics, Inc.; CEO and President, Vermillion, Inc.; CEO, President and Chairman of the Board, Nabi Biopharmaceuticals

Michael J. Donovan, PhD, MD

Graduate from Rutgers University with a B.S. in zoology, a M.S. in endocrinology and a PhD in cell and developmental biology with post-doctoral studies at Harvard Medical School. He received his M.D. from the University of Medicine and Dentistry of New Jersey

CKD Advisory Board

Chirag R Parikh, MD, PhD, Chair

Director, Division of Nephrology, Ronald Peterson Professor of Medicine, Johns Hopkins School of Medicine

Steve Coca, DO, co-Founder

Associate Professor, Medicine, Nephrology; Associate Chair for Clinical and Translational Research for the Department of Internal Medicine, Mount Sinai Health System

Girish Nadkarni, MD, co-Founder

Assistant Professor of Medicine, Division of Nephrology; Clinical Director of the Charles Bronfman Institute for Personalized Medicine Mount Sinai Health System

Judy Cho, MD

Director and Associate Dean for Precision Medicine, Ward-Coleman Professor of Translational Genetics and Medicine Mount Sinai Health System

John Quackenbush, PhD

Professor of Computational Biology and Bioinformatics, Harvard T.H. Chan School of Public Health; Professor of Cancer Biology, Dana-Farber Cancer Institute

Joseph V. Bonventre, MD, PhD

Samuel A. Levine Professor of Medicine, Harvard Medical School. Chief of the Division of Renal Medicine and Chief of the Biomedical Engineering Division, Brigham and Women’s Hospital (BWH)

Barry Freedman, MD, FACP

John H. Felts, III Professor of Medicine and Chief of the Section on Nephrology and Executive Director of the Kidney and Dialysis Service, Wake Forest Baptist Health

Jonathan Himmelfarb, MD

Professor Division of Nephrology University of Washington, Director Kidney Research Institute, Director, Center for Dialysis Innovation, Director Kidney Precision Medicine Project

Joseph Vassalotti, MD, FASN

Chief Medical Officer, National Kidney Foundation, Associate Clinical Professor of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai

George Bakris, MD

Professor of Medicine, University of Chicago, Director, Comprehensive Hypertension Center, Member Board of Directors National Kidney Foundation

John Cijiang He, MD, PhD

Professor of Medicine and Pharmacological Sciences at Icahn School of Medicine at Mount Sinai, Irene and Dr. Arthur Fishberg endowed chair of Nephrology, Chief of Nephrology at Mount Sinai Health System.

Kidney Transplant Advisory Board

Barbara Murphy, MD. Chair

Murray M. Rosenberg Professor of Medicine, Chair of the Department of Medicine and Dean for Clinical Integration & Population Health, Chair of the Kidney Transplant Advisory Board, Mount Sinai Health Systems

Richard Formica, MD

Professor of Medicine (Nephrology) and Professor of Surgery (Transplant); Director of Transplant Medicine; Director Outpatient Transplantation Service; Medical Director Adult and Pediatric Kidney Transplantation; and Medical Director Pancreas Transplantation at Yale School of Medicine

Christian P. Larsen, MD, Dphil

Professor of Surgery, Division of Transplantation, Department of Surgery and the former dean, Emory School of Medicine; founding Director of the Emory Transplant Center

Roslyn B. Mannon, MD

Professor of Medicine in the Division of Nephrology and Professor of Surgery in the Division of Transplantation; Director of Research for the Comprehensive Transplant Institute, University of Alabama at Birmingham Medicine

Peter Nickerson, MD, FRCPC

Clinical Nephrologist, Professor of Internal Medicine and Immunology, and Associate Dean for Research, University of Manitoba; Executive Medical Director, Organs and Tissue Office, at the Canadian Blood Services

Philip O'Connell, MD

Director of the Centre for Transplant and Renal Research and Director of Transplant Medicine and the Clinical Islet Transplant Program, Westmead Hospital

Emilio D. Poggio, MD, FASN

Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of CWRU, and Medical Director, Kidney and Kidney Pancreas Transplant Program, at the Cleveland Clinic

Kathryn Wood, DPhil

Professor of Immunology Emerita in the Nuffield Department of Surgical Sciences at the University of Oxford

Weijia Zhang, PhD

Director, Integrative Bioinformatics and Associate Professor of Medicine, Mount Sinai Health Systems

Advisors

Nominated Adviser

Stifel Nicolaus Europe Limited
150 Cheapside
London
EC2V 6ET

Joint Broker

Stifel Nicolaus Europe Limited
150 Cheapside
London
EC2V 6ET

 

Nplus1 Singer Advisory LLP
1 Bartholomew Lane
London
EC2N 2A

Legal Advisers to the Company

Cooley (UK) LLP
Dashwood
69 Old Broad Street
London
EC2M 1QS

Auditors and Reporting Accountants

PKF Littlejohn LLP
1 Westferry Circus
Canary Wharf
London
E14 4HD

Media & Investor Relations

Walbrook PR Limited
4 Lombard Street
London
EC3V 9HD

Tel: +44 (0)20 7933 8780
renalytix@walbrookpr.com

Registrar

Link Asset Services
The Registry
34 Beckenham Road
Beckenham
Kent
BR3 4TU

Tel: 0871 664 0300
Email: shareholderenquiries@linkgroup.co.uk
Website: www.linkassetservices.com

latest News

03Dec

Medicare sets US national price for KidneyIntelX™

Renalytix AI plc announces that that the Centers for Medicare and Medicaid Services has released the Final 2020 Clinical Laboratory Fee Schedule and has set.. Read More →
21Nov

Grant of Options

Renalytix AI plc announces that the Remuneration Committee agreed to issue options over a total of 50,000 ordinary shares of £0.0025 each in the capital.. Read More →
19Nov

RenalytixAI participating in Capital Markets Day for Kidney Health

Renalytix AI plc, a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announces that it is participating in a London based event focused on.. Read More →